Adamis Pharmaceuticals
- Company typePublic
- Founded2006
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
Adamis Pharmaceuticals firmographics
Firmographics- Name
- Adamis Pharmaceuticals
- Legal name
- Adamis Pharmaceuticals Corporation
- Website
- https://adamispharmaceuticals.com
- Company type
- Public
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Adamis Pharmaceuticals industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)
- akta.pro secondary industry
- Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)
Keywords
Where Adamis Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Adamis Pharmaceuticals business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales
Revenue model
- Product Sales: Revenue from sale of pharmaceutical products including ZIMHI (naloxone for opioid overdose) and SYMJEPI (epinephrine)
Distribution channels1 record
Marketing channels1 record
Adamis Pharmaceuticals product offering
Product offeringCore offering
Adamis Pharmaceuticals develops, manufactures, and commercializes specialty pharmaceutical products focused on neuro-biotechnology indications. Its marketed portfolio includes ZIMHI, a naloxone injection for opioid overdose reversal, and SYMJEPI, an epinephrine product for severe allergic reactions. The company is also advancing a pipeline of investigational therapies, including DPI-125 for opioid use disorder.
Differentiator
Problem solved
Functional benefit
Products and services
- ZIMHI
- SYMJEPI
- DPI-125
Companies that use Adamis Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles2 records
Adamis Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Adamis Pharmaceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DMK PharmaceuticalscoreAdamis Pharmaceuticals announced a merger with DMK Pharmaceuticals, combining capabilities in neuro-biotech product development for opioid overdose and substance use disorders.
Scale indicators3 records
Adamis Pharmaceuticals competitors and assessment
Company assessmentMarket position
Customer concentration
Adamis Pharmaceuticals social profiles
Digital presenceAdamis Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adamis Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles3 records
Adamis Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds6 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adamis Pharmaceuticals M&A and investment
M&A and investmentM&A2 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adamis Pharmaceuticals
What does Adamis Pharmaceuticals do?
Adamis Pharmaceuticals develops, manufactures, and commercializes specialty pharmaceutical products focused on neuro-biotechnology indications. Its marketed portfolio includes ZIMHI, a naloxone injection for opioid overdose reversal, and SYMJEPI, an epinephrine product for severe allergic reactions. The company is also advancing a pipeline of investigational therapies, including DPI-125 for opioid use disorder.
Is Adamis Pharmaceuticals a public or private company?
Adamis Pharmaceuticals is a public company. It is classified as public and is currently operating.
When was Adamis Pharmaceuticals founded?
Adamis Pharmaceuticals was founded in 2006. It employs 11 to 50 people.
Where is Adamis Pharmaceuticals based?
Adamis Pharmaceuticals is headquartered in San Diego, United States, in the North America region.
How does Adamis Pharmaceuticals make money?
One revenue line is on record: product Sales.
Does Adamis Pharmaceuticals have an API?
No public API is recorded for Adamis Pharmaceuticals.
What industry is Adamis Pharmaceuticals in?
Adamis Pharmaceuticals's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAF, Neurology & Psychiatry (CNS) Pharmaceuticals, with a secondary code of HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.